1st Quarter - Report

MEDCO HEALTH SOLUTIONS, INC for MEDCO HEALTH SOLUTIONS INC

Period 1st Quarter 2008 Filed Apr 21, 2008 Signed by Peter Begans, Vice President, Federal Government Affairs

Official filing
Firm
MEDCO HEALTH SOLUTIONS, INC
Client
MEDCO HEALTH SOLUTIONS INC
Income
—
Expenses
$880,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D, Prompt Payment to Pharamcies, Antitrust Exemption for Pharmacists, IVIG Payments, Tracking or Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment. HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 Pharmaceutical Market Access Act of 2007; all aspects S 273 Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 Access to Medicare Data Act of 2007; all aspects S 2219 Medicare Prescription Drug Savings and Choice Act of 2007; all aspects

LobbyistCovered position, as disclosed
PETER BEGANS —
BILL HEAD —
HALLIE LEWIS —
HEATHER STEWART —

Contacted: SENATE; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Executive Office of the President (EOP); Federal Trade Commission (FTC); Labor, Dept of (DOL)

Bills named: H.R. 2567 (110th), H.R. 3700 (110th), H.R. 4296 (110th), H.R. 2606 (110th), H.R. 2914 (110th)

Pharmacy PHA

Electronic Prescribing, Pharmacy Payments, Pharmacy Antitrust Exemption, Internet Pharmacies. HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

LobbyistCovered position, as disclosed
PETER BEGANS —
BILL HEAD —
HALLIE LEWIS —
HEATHER STEWART —

Contacted: Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE

Bills named: H.R. 3193 (110th), H.R. 971 (110th), H.R. 1474 (110th), H.R. 3090 (110th), H.R. 3140 (110th), H.R. 2970 (110th)

Health Issues HCR

Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Contract Dislcosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs. HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects H.R. 5629 - Pathway for Biosimilars Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

LobbyistCovered position, as disclosed
PETER BEGANS —
BILL HEAD —
HALLIE LEWIS —
HEATHER STEWART —

Contacted: Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Federal Trade Commission (FTC); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Justice, Dept of (DOJ); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Bills named: H.R. 3140 (110th), H.R. 493 (110th), S. 1814 (110th), H.R. 3193 (110th), H.R. 971 (110th), H.R. 1432 (110th), H.R. 3090 (110th), H.R. 1956 (110th), S. 316 (110th), H.R. 2606 (110th), H.R. 3932 (110th), H.R. 2567 (110th), H.R. 4296 (110th), H.R. 2914 (110th), H.R. 3800 (110th), H.R. 2970 (110th), H.R. 5629 (110th), H.R. 1474 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.